darbepoetin alfa


Also found in: Medical, Wikipedia.
Translations

darbepoetin alfa

n darbepoetina alfa
References in periodicals archive ?
ENPNewswire-July 30, 2019--Kyowa Kirin Announces Launch of Darbepoetin Alfa Injection syringe [KKF] in Japan
* Aranesp[R] (darbepoetin alfa) sales decreased 9 percent driven primarily by the impact of competition on unit demand.
The objectives of the studies were to evaluate the efficacy and safety of enarodustat in comparison to darbepoetin alfa over 24 weeks, Japan Tobacco explained.
The phase 3 randomised, open-label, active-controlled correction and conversion study assessed the efficacy and safety of vadadustat compared to darbepoetin alfa, an erythropoiesis stimulating agent, in 304 Japanese non-dialysis dependent subjects with anemia due to CKD, with a treatment duration of 52 weeks.
This study evaluated the efficacy and safety of roxadustat compared to darbepoetin alfa in haemodialysis-dependent chronic kidney disease (CKD) patients with anaemia and previously treated with recombinant human erythropoietin (rHuEPO) or darbepoetin alfa.
The 50-50joint venture was launched in 1984 to fund the global development of Epogen (epoetin alfa) and, over time, was expanded to include Neupogen (filgrastim), Neulasta (pegfilgrastim), Aranesp (darbepoetin alfa), Nplate (romiplostim) and brodalumab.
Over time, the scope of the collaboration was expanded to include NEUPOGEN (filgrastim), Neulasta (pegfilgrastim), Aranesp (darbepoetin alfa), Nplate (romiplostim) and brodalumab.
During a review of the marketing application for darbepoetin alfa, an association was found between rate of increase in the hemoglobin level exceeding 1 gram per deciliter per 2-week period and the risk of cardiovascular and thromboembolic event [5].
Darbepoetin alfa is a fastest growing drug class at a CAGR of 12.9% during the forecast period, owing to its high potency and minimal side-effects.
A Cleveland Clinic-led study of a drug called darbepoetin alfa showed that the medication did improve red blood cell levels, but didn't improve rates of hospitalization and mortality for anemic heart failure patients, according to the study results published in the New England Journal of Medicine.